Acute hepatitis B despite a previous high titer of anti-HBs
Tarih
2010Yazar
Tabak, Fehmi
Mete, Bilgul
Ar, Cem
Ozturk, Recep
Ozaras, Resat
Ongoren, Seniz
Mert, Ali
Üst veri
Tüm öğe kaydını gösterÖzet
Loss of HBsAg and development of surface and core antibodies represent clinical cure. However, recent evidence suggests that hepatitis B virus (HBV) persists in a latent state even in those with mounted protective antibodies. After significant immunosuppression, anti-HBs may decrease and HBsAg may reappear (reverse seroconversion). Reverse seroconversion of HBV has been observed in association with hematopoietic stem cell transplantation, renal transplantation, intensive chemotherapy, human immunodeficiency infection, or rituximab usage.
Koleksiyonlar
- Makale [92796]